Every 8-K that INNOVATIVE EYEWEAR INC (LUCYW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow LUCYW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LUCYW filings page.
Innovative Eyewear, Inc. entered an inducement agreement with a warrant holder to immediately exercise 2,200,544 existing warrants at a reduced price of $1.35 per share, generating approximately $3.0 million in gross proceeds. In return, the company is issuing new unregistered Series J warrants to purchase up to 6,601,632 shares of common stock at an exercise price of $1.10 per share, exercisable immediately for 24 months after a future resale registration becomes effective. The company plans to use net proceeds for working capital and general corporate purposes, has engaged H.C. Wainwright & Co. as exclusive placement agent with cash fees and expense reimbursements, and will also issue placement agent warrants to buy 165,041 shares at $1.6875 per share.
Innovative Eyewear, Inc. reported that on August 15, 2025 it filed a prospectus supplement to increase the maximum number of shares of its common stock that may be issued under its existing At The Market Offering Agreement with H.C. Wainwright & Co., originally dated April 15, 2024. This update means the company can issue more common shares through that ongoing at-the-market program as needed, rather than in a single large transaction.
The company also filed a legal opinion from Ellenoff Grossman & Schole LLP, attached as Exhibit 5.1, confirming the legality of issuing and selling these shares. A related consent from the same firm is included as Exhibit 23.1.
Innovative Eyewear, Inc. (Nasdaq: LUCY / LUCYW) filed an 8-K disclosing a cash-for-warrant inducement completed on 20 June 2025. The company persuaded holders of 746,782 existing warrants (originally issued 14 Apr 2025, strike $2.60) to exercise in full. In exchange, the holders purchased—at $0.125 per warrant—2,240,346 new Series I warrants ("New Warrants") that carry the same $2.60 exercise price, are immediately exercisable and expire 18 months after the related resale registration statement becomes effective.
Gross proceeds total approximately $2.2 million (≈ $1.94 million from warrant exercise plus ≈ $0.28 million from New Warrant purchase). Net proceeds will be lower after:
- Placement agent cash fee: 7.5 % of gross
- Management fee: 1.0 % of gross
- Expenses: $90,950 (accountable, non-accountable and clearing)
Placement agent H.C. Wainwright & Co. also received:
- 56,009 PA Warrants (strike $3.25, 18-month term)
- 73,990 Ordinary-Course PA Warrants (strike $3.25, expire 20 Jun 2030)
The company must file a resale registration statement for the New Warrant shares within 30 days and seek SEC effectiveness within 60 days (90 days if fully reviewed). It agreed to:
- Refrain from issuing or registering additional equity for 30 days
- Avoid variable-rate transactions for one year (limited exception)
Use of proceeds: working capital and general corporate purposes.
Capital structure impact: Immediately adds 746,782 common shares; a further 2,240,346 shares (plus 130,000+ PA-related shares) could enter the float if all new warrants are exercised, creating a sizeable potential dilution relative to the modest cash infusion.